REPL — Replimune Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Replimune, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	135	169	476	396	583
Net Total Receivables	2.47	2.96	2.95	3.06	2.94
Prepaid Expenses
Total Current Assets	141	174	484	404	593
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.2	58.2	57.7	55.6	52.4
Other Long Term Assets
Total Assets	154	234	543	461	647
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.88	11.9	14.5	20.8	33.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	16.5	50.4	44.4	50	91.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	138	184	499	411	555
Total Liabilities & Shareholders' Equity	154	234	543	461	647
Total Common Shares Outstanding